Pharmacognosy in the digital era: shifting to contextualized metabolomics. (December 2018)

• Record Type: Journal Article
• Authors: Allard, Pierre-Marie; Bisson, Jonathan; Azzollini, Antonio; Pauli, Guido F; Cordell, Geoffrey A; Wolfender, Jean-Luc
• Is Part Of: Current opinion in biotechnology. Volume 54(2018)
• Page Start: 57
• Page End: 64
• Publication Date: 2018-12
• Subjects: Biotechnology -- Periodicals; 660.6
• DOI: 10.1016/j.copbio.2018.02.010
• Languages: English
• ISSNs: 0958-1669

Abstract

Graphical abstract: Highlights: Metabolomics and pharmacognosy are naturally connected and cross-fertilizing. Contextualization of data is needed to potentiate translational applications. Data-intensive metabolomics methods unveil the need for enhanced data practices. Establishing an ecosystem of open databases will nurture pharmacognosy research. Abstract : Humans have co-evolved alongside numerous other organisms, some having a profound effect on health and nutrition. As the earliest pharmaceutical subject, pharmacognosy has evolved into a meta-discipline devoted to natural biomedical agents and their functional properties. While the acquisition of expanding data volumes is ongoing, contextualization is lagging. Thus, we assert that the establishment of an integrated and open databases ecosystem will nurture the discipline. After proposing an epistemological framework of knowledge acquisition in pharmacognosy, this study focuses on recent computational and analytical approaches. It then elaborates on the flux of research data, where good practices could foster the implementation of more integrated systems, which will in turn help shaping the future of pharmacognosy and determine its constitutional societal relevance.